Our Firm

Our Firm

Green Griffith is a preeminent intellectual property law firm, uniquely qualified to assist small and mid-sized pharmaceutical and biotech companies protect their most valuable assets and position them for future success.
Learn More >
Our Team

Our Team

Our technical knowledge makes the difference: all of our attorneys have degrees in pharma-related fields, including organic chemistry, chemical engineering and molecular biology, and many have advanced degrees.
Learn More >
Our Clients

Our Clients

Our clients are both generics and brand, small and mid-sized pharmaceutical and biotech companies, focused on securing market position and/or overcoming obstacles to new product entry for their drugs and therapies.​​
Learn More >

News and Insights

SCOTUS Signals Interest in Case Concerning Standing to Appeal PTAB Final Written Decisions

The Supreme Court recently ordered briefing from the Solicitor General concerning RPX’s petition for a writ of certiorari (available here)…
Read More >

USPTO Changes Claim Construction Standard for Patent Trial and Appeal Board (PTAB) Proceedings

The USPTO, in a final rule (a copy of which may be accessed here), has changed the claim construction standard to be used by the PTAB in inter pa…
Read More >

Federal Circuit Denies Petition for Rehearing En Banc of Vanda Pharmaceuticals Decision Concerning the Patentability of Method of Treatment Claims Under Section 101

The Federal Circuit’s April 13, 2018, Vanda decision (a copy may be found here) affirmed the district court’s holding that the clai…
Read More >

Federal Circuit Clarifies the Statutory Time Bar Applicable to Petitions for Inter Partes Review

Section 315(b) states, “An inter partes review may not be instituted if the petition requesting the proceeding is filed more than 1 year a…
Read More >